BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 29987402)

  • 1. Hemobilia after CT-guided radiofrequency ablation of liver tumors: frequency, risk factors, and clinical significance.
    Hsieh MF; Chen CB; Chen YL; Chou CT
    Abdom Radiol (NY); 2019 Jan; 44(1):337-345. PubMed ID: 29987402
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hemobilia after radiofrequency ablation of hepatocellular carcinoma.
    Rhim H; Lim HK; Kim YS; Choi D; Lee KT
    Abdom Imaging; 2007 Nov; 32(6):719-24. PubMed ID: 17171515
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Value of Nonrigid Registration of Pre-Procedure MR with Post-Procedure CT After Radiofrequency Ablation for Hepatocellular Carcinoma.
    Park J; Lee JM; Lee DH; Joo I; Yoon JH; Park JY; Klotz E
    Cardiovasc Intervent Radiol; 2017 Jun; 40(6):873-883. PubMed ID: 28091728
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is Antibiotic Prophylaxis for Percutaneous Radiofrequency Ablation (RFA) of Primary Liver Tumors Necessary? Results From a Single-Center Experience.
    Bhatia SS; Spector S; Echenique A; Froud T; Suthar R; Lawson I; Dalal R; Dinh V; Yrizarry J; Narayanan G
    Cardiovasc Intervent Radiol; 2015 Aug; 38(4):922-8. PubMed ID: 25392237
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Computed tomography (CT)-guided versus laparoscopic radiofrequency ablation: a single-institution comparison of morbidity rates and hospital costs.
    Cassera MA; Potter KW; Ujiki MB; Swanström LL; Hansen PD
    Surg Endosc; 2011 Apr; 25(4):1088-95. PubMed ID: 20848143
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radiofrequency ablation of liver metastases-software-assisted evaluation of the ablation zone in MDCT: tumor-free follow-up versus local recurrent disease.
    Keil S; Bruners P; Schiffl K; Sedlmair M; Mühlenbruch G; Günther RW; Das M; Mahnken AH
    Cardiovasc Intervent Radiol; 2010 Apr; 33(2):297-306. PubMed ID: 19688366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A case of hemocholecyst associated with hemobilia following radiofrequency ablation therapy for hepatocellular carcinoma.
    Shin KY; Heo J; Kim JY; Lee SJ; Jang SY; Park SY; Jung MK; Cho CM; Tak WY; Kweon YO
    Korean J Hepatol; 2011 Jun; 17(2):148-51. PubMed ID: 21757986
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Locoregional recurrences are frequent after radiofrequency ablation for hepatocellular carcinoma.
    Harrison LE; Koneru B; Baramipour P; Fisher A; Barone A; Wilson D; Dela Torre A; Cho KC; Contractor D; Korogodsky M
    J Am Coll Surg; 2003 Nov; 197(5):759-64. PubMed ID: 14585410
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined transarterial chemoembolization and radiofrequency ablation for small treatment-naïve hepatocellular carcinoma infeasible for ultrasound-guided radiofrequency ablation: long-term outcomes.
    Hyun D; Cho SK; Shin SW; Park KB; Lee SY; Park HS; Do YS
    Acta Radiol; 2018 Jul; 59(7):773-781. PubMed ID: 29034691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The occurrence and clinical significance of contrast agent spillover on immediate enhanced CT reexamination after radiofrequency ablation of liver cancer].
    Gao QZ; Wang ZW; Pan J; Shi HF; Zhang XB; Jin ZY
    Zhonghua Gan Zang Bing Za Zhi; 2018 Jul; 26(7):503-507. PubMed ID: 30317772
    [No Abstract]   [Full Text] [Related]  

  • 11. The development of a predictive risk model on post-ablation hemobilia: a multicenter matched case-control study.
    Liu B; Li H; Guo J; Duan Y; Li C; Chen J; Zheng J; Li W
    Br J Radiol; 2021 Feb; 94(1118):20200163. PubMed ID: 33353395
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Frequency of and risk factors for complications after liver radiofrequency ablation under CT fluoroscopic guidance in 1500 sessions: single-center experience.
    Takaki H; Yamakado K; Nakatsuka A; Yamada T; Shiraki K; Takei Y; Takeda K
    AJR Am J Roentgenol; 2013 Mar; 200(3):658-64. PubMed ID: 23436859
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hemorrhagic complications of percutaneous radiofrequency ablation for liver tumors.
    Goto E; Tateishi R; Shiina S; Masuzaki R; Enooku K; Sato T; Ohki T; Kondo Y; Goto T; Yoshida H; Omata M
    J Clin Gastroenterol; 2010; 44(5):374-80. PubMed ID: 19809357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical application of ultrasound-guided radiofrequency ablation for primary hepatocellular carcinoma near the liver surface].
    Wu J; Lin S; Wu W; Yan K; Dai Q; Chen M
    Zhonghua Zhong Liu Za Zhi; 2015 Dec; 37(12):933-7. PubMed ID: 26887624
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determinants of local progression after computed tomography-guided percutaneous radiofrequency ablation for unresectable lung tumors: 9-year experience in a single institution.
    Okuma T; Matsuoka T; Yamamoto A; Oyama Y; Hamamoto S; Toyoshima M; Nakamura K; Miki Y
    Cardiovasc Intervent Radiol; 2010 Aug; 33(4):787-93. PubMed ID: 19967367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Laparoscopic vs computerized tomography-guided radiofrequency ablation for large hepatic hemangiomas abutting the diaphragm.
    Gao J; Kong J; Ding XM; Ke S; Niu HG; Xin ZH; Ning CM; Guo SG; Li XL; Zhang L; Dong YH; Sun WB
    World J Gastroenterol; 2015 May; 21(19):5941-9. PubMed ID: 26019459
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Percutaneous radiofrequency ablation of malignant liver tumors with ultrasound and CT fusion imaging guidance.
    Xu ZF; Xie XY; Kuang M; Liu GJ; Chen LD; Zheng YL; Lu MD
    J Clin Ultrasound; 2014; 42(6):321-30. PubMed ID: 24615771
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The minimal ablative margin of radiofrequency ablation of hepatocellular carcinoma (> 2 and < 5 cm) needed to prevent local tumor progression: 3D quantitative assessment using CT image fusion.
    Kim YS; Lee WJ; Rhim H; Lim HK; Choi D; Lee JY
    AJR Am J Roentgenol; 2010 Sep; 195(3):758-65. PubMed ID: 20729457
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oblique approach for CT-guided liver radiofrequency ablation using multiplanar reformation images in hepatocellular carcinoma.
    Kamei S; Matsuda J; Hagihara M; Kitagawa A; Izumi Y; Katsuda E; Oshima Y; Ikeda S; Kimura J; Ota T; Kawamura T; Ishiguchi T
    Jpn J Radiol; 2012 Jul; 30(6):533-9. PubMed ID: 22528338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessing the Effect of Weight-Based Protocol Modifications to Lower Dose for CT-Guided Hepatic and Renal Tumor Radiofrequency Ablations.
    Gupta S; Arellano RS; Gervais DA; Sahani DV
    AJR Am J Roentgenol; 2018 Mar; 210(3):657-662. PubMed ID: 29323550
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.